Award
Definitive Contract #75A50326C00012
Definitive Contract Awarded to Hikma Pharmaceuticals for Diazepam Replenishment
Buyer
Office of Assistant Secretary for Preparedness and Response
Award Amount
$7,521,325.00
Ceiling
$7,521,325.00
Awarded
September 30, 2026
Period of Performance
Sep 30, 2026 – Sep 29, 2027
Identifier
75A50326C00012
NAICS
325412
This definitive contract was awarded to Hikma Pharmaceuticals USA Inc., a leading pharmaceutical company specializing in medication manufacturing and distribution. The contract focuses on the replenishment of diazepam stocks as part of the Fiscal Year 2026 Strategic National Stockpile (SNS) pharmaceutical logistics efforts. Diazepam is a critical medication used for its anxiolytic and anticonvulsant properties, making its availability essential for national health security and emergency preparedness. The scope of work includes supplying and managing the logistics of diazepam to maintain a robust pharmaceutical stockpile. The contract was competitively awarded based on stringent criteria to ensure a reliable supply chain. It is set for a one-year period, beginning in late 2026, with performance centered in Atlanta, Georgia. This award plays a vital role in ensuring readiness and resilience in public health response capabilities.
Description
FY26 SNS PHARMACEUTICAL LOGISTIC REPLENISHMENT - DIAZEPAM